Molecule Details
InChIKeyCJBJHOAVZSMMDJ-HEXNFIEUSA-N
Compound NameDarunavir
Canonical SMILESCC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Homologous
Avg pChEMBL10.15
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB01264
Drug NameDarunavir
CAS Number206361-99-1
Groups approved investigational
ATC Codes J05AR14 G01AE10 J05AR22 J05AR26 J05AE10
DescriptionDarunavir is a protease inhibitor used with other HIV protease inhibitor drugs as well as [ritonavir] for the effective management of HIV-1 infection.[L9227] As a second-generation protease inhibitor, darunavir is designed to combat resistance to standard HIV therapy.[A2278,A2281] It was initially a...

Categories: Amides Anti-HIV Agents Anti-Infective Agents Anti-Retroviral Agents Antiinfectives for Systemic Use Antiviral Agents Antivirals for Systemic Use Antivirals used in combination for the treatment of HIV infections Carbamates Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Inhibitors (strong) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Direct Acting Antivirals Enzyme Inhibitors Experimental Unapproved Treatments for COVID-19 Furans Genito Urinary System and Sex Hormones Gynecological Antiinfectives and Antiseptics HIV Protease Inhibitors Hyperglycemia-Associated Agents OATP1B1/SLCO1B1 Inhibitors P-glycoprotein inducers P-glycoprotein inhibitors P-glycoprotein substrates Protease Inhibitors Sulfonamides Sulfones Sulfur Compounds Viral Protease Inhibitors
Cross-references: BindingDB: 8125 ChEBI: 367163 CHEMBL1323 ChemSpider: 184733 Drugs Product Database (DPD): 19793 D03656 PDB: 017 PharmGKB: PA163522472 PubChem:213039 PubChem:46506908 RxCUI: 460132 Therapeutic Targets Database: DAP001086 Wikipedia: Darunavir ZINC: ZINC000003955219
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
Q9QBY3 gag-pol Human immunodeficiency virus type 1 group M subtype K (isolate 96CM-MP535) Pathogen PF00540 PF19317 PF00552 PF02022 PF00075 PF00665 PF00077 PF00078 PF06815 PF06817 PF00098 10.6 Ki BindingDB
Q9YQ12 protease Human immunodeficiency virus type 1 Pathogen PF00077 10.6 Ki ChEMBL;BindingDB
Q72874 pol Human immunodeficiency virus type 1 Pathogen PF00077 9.2 Ki ChEMBL
DrugBank Target Actions (11)
Target Gene Target Name Action Type
P02763 P02763 Alpha-1-acid glycoprotein 1 substrate carriers
P02768 ALB Albumin substrate carriers
P08684 CYP3A4 Cytochrome P450 3A4 inhibitor enzymes
P10635 CYP2D6 Cytochrome P450 2D6 inhibitor enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
Q72874 pol Pol polyprotein inhibitor targets
P03366 gag-pol Gag-Pol polyprotein modulator targets
P08183 ABCB1 ATP-dependent translocase ABCB1 inducer transporters
P08183 ABCB1 ATP-dependent translocase ABCB1 inhibitor transporters
Q9Y6L6 SLCO1B1 Solute carrier organic anion transporter family member 1B1 inhibitor transporters
P08183 ABCB1 ATP-dependent translocase ABCB1 substrate transporters